About Joint Actions

Joint Actions are the main way CAMD will achieve its aims of enhancing collaboration, improving market surveillance and coordinating better communication across the Member States.

JAMS 2.0: Joint Action on Reinforced Market Surveillance of Medical Devices and In Vitro Medical Devices

JAMS 2.0 is a Joint Action from the EU4Health Program. It aims to reinforce the market surveillance of medical devices between Member States and to harmonise approaches across the European Union. 

Comprised of 24 Competent Authorities, the Joint Action officially started on November 1st, 2023. It will last 36 months, as final results are expected for October 2026. JAMS 2.0 is divided in 8 Work Packages, all contributing to the achievement of the main objectives:

  1. Coordination (ANSM, France)
  2. Communication and Dissemination (ANSM, France)
  3. Evaluation (URPL, Poland)
  4. Sustainability (JAZMP, Slovenia)
  5. Signal detection in vigilance (MMA, Malta)
  6. Inspection (FAMHP, Belgium)
  7. Market Surveillance Campaigns (AEMPS, Spain)
  8. MD/IVS University (ANSM, France)

Find out more about JAMS 2.0

Joint Action on Market Surveillance of Medical Devices

On 19 October 2016, at the 39th meeting of the Competent Authorities for Medical Devices in Bratislava, Slovakia, was officially launched the Joint Action in Market Surveillance of Medical Devices (JAMS).

The project aims to reinforce the market surveillance system for medical devices by improving the coordination of activities by all Member States of the European Union, and ensuring adequate communications and cooperation. These are crucial for success and effectiveness of the market surveillance in the field of medical devices. The Joint Action will be implemented through five work packages:

  1. Coordination (ANSM, France)
  2. Dissemination (ANSM, France)
  3. Evaluation (ANSM, France)
  4. Manufacturers’ inspections (ANSM, France and INFARMED, Portugal)
  5. Clinical process and resource development (HPRA, Ireland)

Find out more about the Joint Action on Market Surveillance of Medical Devices.

COEN Joint Action 2014: Instructions for use for re-useable and re-sterilisable medical devices

COEN Joint Action 2014: Instructions for use for re-useable and re-sterilisable medical devices (COEN2014) is focused on improving co-ordination, harmonisation and supervision of the medical device market. It specifically aims to improve the standards and levels of compliance of medical devices intended to be re-used.

Find out more about COENJA2014.